Q4 2024 · 13F-HR
RA CAPITAL MANAGEMENT, L.P.holdings as filed
Filed 2025-02-14 · accession 0001104659-25-014181
$7.51B
Reported value
89
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S - ADR | $1.39B | 18.5% | 10,112,744 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $711.3M | 9.47% | 8,689,190 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $555.0M | 7.39% | 10,365,652 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $340.6M | 4.53% | 6,084,412 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP-ADR | $244.3M | 3.25% | 7,506,934 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $237.9M | 3.17% | 8,909,091 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA CO NV | $227.3M | 3.03% | 8,845,000 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $225.2M | 3.00% | 18,202,009 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $213.8M | 2.84% | 2,787,327 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $183.2M | 2.44% | 6,300,408 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $160.2M | 2.13% | 6,995,858 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $150.3M | 2.00% | 6,381,144 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $147.9M | 1.97% | 10,637,290 | Common | SOLE |
| 78349D107 | RXST | RXSIGHT INC | $128.7M | 1.71% | 3,743,018 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $121.2M | 1.61% | 6,955,993 | Common | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $120.6M | 1.61% | 4,178,823 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $114.6M | 1.52% | 10,860,977 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $110.9M | 1.48% | 14,175,398 | Common | SOLE |
| 78464A870 | XBI | SPDR S&P BIOTECH ETF | $110.6M | 1.47% | 1,228,240 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $106.2M | 1.41% | 30,009,536 | Common | SOLE |
| 04317A107 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $99.3M | 1.32% | 9,853,302 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $84.6M | 1.13% | 1,000,000 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC - ADR | $82.1M | 1.09% | 1,766,830 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $72.9M | 0.97% | 5,755,577 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $71.1M | 0.95% | 1,569,491 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $59.7M | 0.79% | 4,850,984 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $58.6M | 0.78% | 761,955 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $56.6M | 0.75% | 31,419,267 | Common | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS-A | $52.2M | 0.69% | 7,725,096 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $51.5M | 0.69% | 2,538,925 | Common | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $50.2M | 0.67% | 8,340,508 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $48.1M | 0.64% | 10,229,099 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC-CLASS A | $47.1M | 0.63% | 3,279,401 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $46.8M | 0.62% | 6,686,689 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $45.6M | 0.61% | 5,105,213 | Common | SOLE |
| 929033108 | — | VOR BIOPHARMA INC | $44.0M | 0.59% | 39,646,039 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $41.2M | 0.55% | 1,517,418 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $40.7M | 0.54% | 1,866,400 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $40.5M | 0.54% | 10,689,545 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC - A | $40.2M | 0.54% | 3,577,197 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $38.8M | 0.52% | 4,451,041 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $34.6M | 0.46% | 1,347,252 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD-ADR | $33.9M | 0.45% | 1,295,040 | Common | SOLE |
| 16934W106 | CMRXEUR | CHIMERIX INC | $30.6M | 0.41% | 8,800,000 | Common | SOLE |
| 171757206 | CDTX | CIDARA THERAPEUTICS INC | $29.4M | 0.39% | 1,092,796 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $27.9M | 0.37% | 1,511,334 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $26.9M | 0.36% | 10,805,129 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $25.7M | 0.34% | 14,932,063 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $25.4M | 0.34% | 4,563,211 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $25.1M | 0.33% | 1,333,333 | Common | SOLE |
| 81749D107 | SERA | SERA PROGNOSTICS INC-A | $24.7M | 0.33% | 3,032,808 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $24.4M | 0.32% | 9,192,092 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $23.7M | 0.32% | 3,181,818 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $23.4M | 0.31% | 6,045,351 | Common | SOLE |
| 15678C102 | CBLL | CERIBELL INC | $21.3M | 0.28% | 824,582 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $20.0M | 0.27% | 1,150,000 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $19.1M | 0.25% | 848,986 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $18.8M | 0.25% | 10,872,503 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $18.3M | 0.24% | 9,695,228 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTIC INC | $18.0M | 0.24% | 3,400,000 | Common | SOLE |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $17.6M | 0.23% | 4,878,000 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $17.3M | 0.23% | 4,330,446 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $16.9M | 0.22% | 1,281,000 | Common | SOLE |
| 10919W405 | DRUG | Bright Minds Biosciences Inc | $16.6M | 0.22% | 460,829 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $16.1M | 0.21% | 2,092,259 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC-ADR | $15.3M | 0.20% | 1,093,477 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $14.7M | 0.20% | 3,566,338 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $13.8M | 0.18% | 200,000 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $13.2M | 0.18% | 575,000 | Common | SOLE |
| N44445109 | IMTX | IMMATICS NV | $12.4M | 0.17% | 1,750,000 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $11.6M | 0.15% | 4,666,667 | Common | SOLE |
| 61023L207 | MNPR | MONOPAR THERAPEUTICS INC | $11.2M | 0.15% | 511,207 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $9.9M | 0.13% | 960,620 | Common | SOLE |
| 95075A107 | HOWL | WEREWOLF THERAPEUTICS INC | $9.1M | 0.12% | 6,144,881 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $8.1M | 0.11% | 421,348 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $8.0M | 0.11% | 3,217,503 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAPITAL SOLUTIONS | $7.6M | 0.10% | 750,000 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $7.6M | 0.10% | 1,310,589 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $7.3M | 0.10% | 7,541,000 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $7.2M | 0.10% | 967,000 | Common | SOLE |
| 10170A100 | BOLD | BOUNDLESS BIO INC | $6.3M | 0.08% | 2,180,631 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $6.0M | 0.08% | 1,038,000 | Common | SOLE |
| N62509117 | NAMSW | NEWAMSTERDAM PHARMA CO NV-27 | $4.7M | 0.06% | 333,333 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $4.1M | 0.05% | 282,580 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $3.6M | 0.05% | 546,554 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $1.4M | 0.02% | 1,129,931 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HOLDING CORP | $761,364 | 0.01% | 17,616 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $532,212 | 0.01% | 336,843 | Common | SOLE |
| 80880W106 | SCLXUSD | SCILEX HOLDING CO | $441,843 | 0.01% | 1,036,218 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.